tocilizumab-anoh 20 MG/ML per 10 ML Injection

RxCUI: 2705443
RxNorm name: tocilizumab-anoh 20 MG/ML per 10 ML Injection
Display name: tocilizumab-anoh 20 MG/ML per 10 ML Injection
Full name: tocilizumab-anoh 20 MG/ML per 10 ML Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:00

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761420	Avtozma	tocilizumab-anoh	351(k) Interchangeable	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
AVTOZMA	TOCILIZUMAB	CELLTRION USA, Inc.	581c288f-8015-40ef-a4c3-683c96db193d	2026-07-27	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2705443

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
581c288f-8015-40ef-a4c3-683c96db193d	tocilizumab-anoh 200 MG in 10 ML Injection [PSN] · 10 ML tocilizumab-anoh 20 MG/ML Injection [SCD] · tocilizumab-anoh 20 MG/ML per 10 ML Injection [SY] · tocilizumab-anoh 200 MG per 10 ML Injection [SY]	4	4	These highlights do not include all the information needed to use AVTOZMA safely and effectively. See full prescribing information for AVTOZMA. AVTOZMA ® (tocilizumab-anoh) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2025 AVTOZMA (tocilizumab-anoh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful	20260123
60381a7e-d7ae-4384-925d-c19c418d1663	tocilizumab-anoh 200 MG in 10 ML Injection [PSN] · 10 ML tocilizumab-anoh 20 MG/ML Injection [SCD] · tocilizumab-anoh 20 MG/ML per 10 ML Injection [SY] · tocilizumab-anoh 200 MG per 10 ML Injection [SY]	4	4	These highlights do not include all the information needed to use TOCILIZUMAB-ANOH safely and effectively. See full prescribing information for TOCILIZUMAB-ANOH. TOCILIZUMAB-ANOH injection, for intravenous or subcutaneous use Initial U.S. Approval: 2025 Tocilizumab-anoh is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful dif	20260123